期刊文献+

2006-2008年我院降糖药应用分析 被引量:6

Utilization of hypoglycemic drugs during 2006—2008 in our hospital
暂未订购
导出
摘要 目的:分析本院降糖药的用药情况和变化趋势,为临床合理用药提供参考。方法:对本院2006—2008年药库出库药品种类和销售金额进行分析。结果:降糖药的销售金额呈逐年上升趋势。噻唑烷二酮类上升趋势明显,胰岛素及其衍生物的发展有良好的前景。结论:本院降糖药的使用基本合理。 Objective:To evaluate the status and developmental trend of the use of hypoglycemic drugs in our hospital from 2006--2008, so as to provide reference for clinical rational medication of antidiabetic drugs. Methods : The consumption sum of hypoglycemic drugs used in our hospital from 2006 to 2008 were statistically analyzed. Results: The consumption sum of hypoglycemic drugs has been on the rise every year. The thiazolidine - dione increased markedly. Insulin and its derivatives have a good prospect. Conclusion:The utilization of hypoglycemic drugs in our hospital is rational.
出处 《天津药学》 2010年第2期28-29,共2页 Tianjin Pharmacy
关键词 降糖药 用药分析 hypoglycemic drugs, insulin, utilization
  • 相关文献

参考文献3

二级参考文献25

  • 1许恒忠,李金英,韩恩祥.口服降糖药的临床应用进展[J].医药导报,2007,26(1):52-54. 被引量:26
  • 2李春霖.糖尿病治疗新进展[J].中国药物应用与监测,2007,4(1):1-3. 被引量:9
  • 3[1]Kramer W, Muller G, Girbig F, et al. Differential interaction of glimepiride and glibenclamide with the βcell sulfonylurea receptor Ⅱ.Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride. Biochim Biophys Acta, 1994, 1191(2):278
  • 4[2]Muller G, Hartz D, Punter J, et al. Differential interaction of glimepiride and glibenclamide with the β-cell sulfonylurea receptor Ⅰ. Binding characteristics. Biochim Biophys Acta, 1994,1191(2):267
  • 5[3]Massi-Bendetti M, Herz M, Pfeiffer C. The effects of acute exercise on metabolic control in type Ⅱ diabetic patients treated with glimepiride and glibenclamide. Horm Metab Res, 1996,28(9) :451
  • 6[4]Geisen K, Vegh A, Krause E, et al. Cardiovascular effects of conventional sulfony1ureas and glimepiride. Horm Metab Res,1996, 28(9):496
  • 7[5]Bijlstra PJ, Lutterman JA, Rusel FG, et al. Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans. Diabetologia, 1996, 39 (9):1083
  • 8[6]Muller G, Satoh Y, Geisen K. Extra-pancreatic effects of sulfonylurea-a comparison between glimepiride and conventional sulfonylurea. Diabetes Res Clin Pract, 1995(Suppl 28):115
  • 9Pitiporn S, Cyrus D, Sunil A. Cardiovascular effects of thiazolinediones[J]. The Endocrinologist, 2002, 12(2): 126.
  • 10NolanJ J, Jones NP, Patwarchum R, et al. Rosiglitazone taken once daily provides effective glycaemic control in patients with type 2 diabetesmellitus[ J]. Diabet Med, 2000, 17 (2):287.

共引文献43

同被引文献46

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部